Zircol 20 lercanidipine hydrochloride

Zircol is a prescription-only pharmaceutical product used primarily for the treatment of hypertension (high blood pressure). The active ingredient, lercanidipine hydrochloride, belongs to a class of drugs known as calcium channel blockers.

The brand is currently part of the Viatris portfolio. Viatris was formed in late 2020 through the merger of Mylan and Upjohn (a legacy division of Pfizer). While the brand has global reach, this specific packaging (indicated by the AUST R number) is tailored for the Australian market. Manufacturing for such generic and branded-generic pharmaceuticals typically occurs across a global network of facilities, including sites in Ireland, India, and various European countries, depending on the specific supply chain for the region.